Chronic intraperitoneal injection of lipopolysaccharide (LPS), which simulates systemic bacterial infection in mice, has been shown to promote TDP‐43 mislocalization, a pathological feature observed in approximately 95% of ALS cases [44]. The gene discussed is TARDBP; the disease is bacterial infectious disease.